MLFMV Stock Overview
Through its subsidiaries, engages in the pharmacies, pharmaceutical distribution, information technologies, healthcare, health market intelligence, real estate, and other services businesses.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Farminveste, S.G.P.S., S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.20 |
52 Week High | €1.50 |
52 Week Low | €1.20 |
Beta | 0.34 |
11 Month Change | -20.00% |
3 Month Change | -14.29% |
1 Year Change | -45.45% |
33 Year Change | -44.95% |
5 Year Change | -74.47% |
Change since IPO | -76.24% |
Recent News & Updates
These 4 Measures Indicate That Farminveste S.G.P.S (ELI:MLFMV) Is Using Debt Extensively
Jun 27Some Investors May Be Worried About Farminveste S.G.P.S' (ELI:MLFMV) Returns On Capital
Dec 15Recent updates
These 4 Measures Indicate That Farminveste S.G.P.S (ELI:MLFMV) Is Using Debt Extensively
Jun 27Some Investors May Be Worried About Farminveste S.G.P.S' (ELI:MLFMV) Returns On Capital
Dec 15Farminveste S.G.P.S (ELI:MLFMV) Has A Somewhat Strained Balance Sheet
Jun 30Be Wary Of Farminveste S.G.P.S (ELI:MLFMV) And Its Returns On Capital
Feb 09Farminveste S.G.P.S (ELI:MLFMV) Will Be Looking To Turn Around Its Returns
Sep 05Farminveste S.G.P.S (ELI:MLFMV) Has More To Do To Multiply In Value Going Forward
May 23These Return Metrics Don't Make Farminveste S.G.P.S (ELI:MLFMV) Look Too Strong
Feb 08Here's Why Farminveste S.G.P.S (ELI:MLFMV) Is Weighed Down By Its Debt Load
Oct 23Farminveste S.G.P.S (ELI:MLFMV) Is Finding It Tricky To Allocate Its Capital
Aug 31Here's What To Make Of Farminveste S.G.P.S' (ELI:MLFMV) Decelerating Rates Of Return
May 18Should We Be Excited About The Trends Of Returns At Farminveste S.G.P.S (ELI:MLFMV)?
Feb 01Farminveste S.G.P.S (ELI:MLFMV) Has A Somewhat Strained Balance Sheet
Dec 09Shareholder Returns
MLFMV | PT Healthcare | PT Market | |
---|---|---|---|
7D | -20.0% | -1.1% | -0.3% |
1Y | -45.5% | -1.4% | -3.6% |
Return vs Industry: MLFMV underperformed the Portuguese Healthcare industry which returned -1.4% over the past year.
Return vs Market: MLFMV underperformed the Portuguese Market which returned -3.6% over the past year.
Price Volatility
MLFMV volatility | |
---|---|
MLFMV Average Weekly Movement | 7.4% |
Healthcare Industry Average Movement | 5.0% |
Market Average Movement | 3.7% |
10% most volatile stocks in PT Market | 8.1% |
10% least volatile stocks in PT Market | 1.6% |
Stable Share Price: MLFMV has not had significant price volatility in the past 3 months.
Volatility Over Time: MLFMV's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Portuguese stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 1,851 | n/a | www.farminveste-sgps.com |
Farminveste, S.G.P.S., S.A., through its subsidiaries, engages in the pharmacies, pharmaceutical distribution, information technologies, healthcare, health market intelligence, real estate, and other services businesses. It distributes pharmaceutical products in Portugal; operates approximately 10 hospitals and 9 clinics in Lisbon, Almada, Oeiras, Cascais, Sintra, Mafra, Torres Vedras, Santarém, Coimbra, Viseu, S. João da Madeira, Matosinhos, and Porto; and provides consultancy and technological services in the healthcare sector. The company is also involved in the market research study in the health area in Portugal, Spain, and Ireland; and operation of pharmacies.
Farminveste, S.G.P.S., S.A. Fundamentals Summary
MLFMV fundamental statistics | |
---|---|
Market cap | €24.00m |
Earnings (TTM) | €9.95m |
Revenue (TTM) | €852.77m |
2.4x
P/E Ratio0.0x
P/S RatioIs MLFMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MLFMV income statement (TTM) | |
---|---|
Revenue | €852.77m |
Cost of Revenue | €741.13m |
Gross Profit | €111.64m |
Other Expenses | €101.69m |
Earnings | €9.95m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.50 |
Gross Margin | 13.09% |
Net Profit Margin | 1.17% |
Debt/Equity Ratio | 113.6% |
How did MLFMV perform over the long term?
See historical performance and comparison